共 10 条
- [1] Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil. Boussen H,Cvitkovic E,Wendling J L,Azli N,Bachouchi M,Mahjoubi R,Kalifa C,Wibault P,Schwaab G,Armand J P. Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 1991
- [2] Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Ma J,Mai HQ,Hong MH,et al. Journal of Clinical Oncology . 2001
- [3] Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies. Perri Francesco,Bosso Davide,Buonerba Carlo,Lorenzo Giuseppe Di,Scarpati Giuseppina Della Vittoria. World journal of clinical oncology . 2011
- [4] Integrated therapeutic approaches in head and neck cancer:the importance of multidisciplinary team management. Perri F,Muto P,Aversa C,Daponte A,Della Vittoria G,Pepe S,Caponigro F. Anticancer Agents Med Chem . 2013
- [5] Induction docetaxel-cisplatin followed by extended-field radiotherapy in patients with cervical metastases from unknown primary carcinoma. Perri F,lonna F,Muto P,et al. Anticancer Research . 2013
- [6] How successful is high-dose (≥60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 40 (04): : 897 - 913
- [7] Recurrent nasopharyngeal carcinoma: current management approaches. Smee Robert I,Meagher Nicola S,Broadley Kathryn,Ho Timothy,Williams Janet R,Bridger G Patrick. American journal of clinical oncology . 2009
- [8] Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer. Roeder Falk,Zwicker Felix,Saleh-Ebrahimi Ladan,Timke Carmen,Thieke Christian,Bischof Marc,Debus Juergen,Huber Peter. Radiation Oncology . 2011
- [9] Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma. Anthony T.C. Chan,Mow-Ming Hsu,Boon C. Goh,Edwin P. Hui,Tsang-Wu Liu,Michael J. Millward,Ruey-Long Hong,Jacqueline Whang-Peng,Brigette B.Y. Ma,Ka F. To,Matthias Mueser,Nadia Amellal,Xiao Lin,Alex Y. Cha. Japanese Journal of Clinical Oncology . 2005
- [10] Treatment approaches to nasopharyngeal carcinoma: a review. Caponigro Francesco,Longo Francesco,Ionna Franco,Perri Francesco. Anti Cancer Drugs . 2010